Key result
DOAC use prior to traumatic brain injury was associated with more favorable disposition and functional outcome at discharge compared to vitamin K antagonists.
Why the study?
Do DOACs improve functional outcomes and reduce hemorrhage expansion in patients with traumatic brain injury compared to vitamin K antagonists?
Do DOACs improve functional outcomes and reduce hemorrhage expansion in patients with traumatic brain injury compared to vitamin K antagonists?
In patients with traumatic brain injury, prior use of DOACs may be associated with better functional outcomes at discharge compared to vitamin K antagonists, though larger prospective registries are needed to confirm these findings.
No takes yet. Share an insight, caveat, or question.
Katja E. Wartenberg (2020) conducted an editorial in Traumatic Brain Injury (TBI) (n=136). Direct oral anticoagulants (DOACs) vs. Vitamin K antagonists (VKA) was evaluated on Functional outcome at discharge (Glasgow outcome scale). DOAC use prior to traumatic brain injury was associated with more favorable disposition and functional outcome at discharge compared to vitamin K antagonists.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: